![Table 5 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar Table 5 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9aa26a502209d679ad4bbd653defba9a47cbe4e/39-Table5-1.png)
Table 5 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar
![Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension | SpringerLink Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40261-013-0094-9/MediaObjects/40261_2013_94_Fig1_HTML.gif)
Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension | SpringerLink
![Table 4 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar Table 4 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9aa26a502209d679ad4bbd653defba9a47cbe4e/38-Table4-1.png)
Table 4 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar
![Table 2 from Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? | Semantic Scholar Table 2 from Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d943094ae2a455dbbbacc0c58cc69b877d929bbb/5-Table1-1.png)
Table 2 from Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? | Semantic Scholar
USE OF A POLYPILL TO REDUCE CARDIOVASCULAR RISK FACTORS IN PRIMARY AND SECONDARY PREVENTION: REVIEW AND USE GUIDELINES
![Determination of Losartan Potassium and Perindopril Erbumine in Tablet Formulations by Reversed-Phase HPLC | Semantic Scholar Determination of Losartan Potassium and Perindopril Erbumine in Tablet Formulations by Reversed-Phase HPLC | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0776d98a61f4c9b468364089193ae76258d27f28/4-Table3-1.png)
Determination of Losartan Potassium and Perindopril Erbumine in Tablet Formulations by Reversed-Phase HPLC | Semantic Scholar
![IJERPH | Free Full-Text | Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials IJERPH | Free Full-Text | Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials](https://www.mdpi.com/ijerph/ijerph-19-08373/article_deploy/html/images/ijerph-19-08373-g001.png)
IJERPH | Free Full-Text | Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study - Document - Gale Academic OneFile
![Table 6 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar Table 6 from Angiotensin-Converting Enzyme (ACE) Inhibitors in Heart Failure:Reducing Mortality and Costs to the NHS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9aa26a502209d679ad4bbd653defba9a47cbe4e/40-Table6-1.png)